The Experts below are selected from a list of 103398 Experts worldwide ranked by ideXlab platform

Eric A F Simoes - One of the best experts on this subject based on the ideXlab platform.

  • risk factors for severe Respiratory syncytial virus lower Respiratory Tract Infection
    The Open Microbiology Journal, 2011
    Co-Authors: Constanze Sommer, Bernhard Resch, Eric A F Simoes
    Abstract:

    RSV Infection is a leading cause of lower Respiratory Tract Infection, especially in High-risk infants with a history of prematurity, bronchopulmonary dysplasia (BPD), congenital heart disease (CHD), neuromusculair impairment, immunodeficiency, and Down syndrome. Host related risk factors that have been identified to be associated with severe RSV related lower Respiratory Tract Infection include young age below 6 months at the beginning of RSV season, multiple birth, male sex, low socioeconomic status and parental education, crowded living conditions, young siblings, maternal smoking and indoor smoke pollution, malnutrition/small for gestational age, family history of atopy or asthma, low cord serum RSV antibody titers, and living at altitude. Risk factors increasing the risk of acquisition of RSV have been identified to be birth before and/or during RSV season, day care attendance, presence of older siblings in school or day-care, and lack of breast feeding. Some of these risk factors are discussed controversially and some of them are found continuously throughout the literature. Given the high cost of RSV prophylaxis, especially for the large population of late preterm infants, algorithms and risk score systems have been published that could identify high-risk infants for treatment with palivizumab out of this gestational age group. Several models reported on an average sensitivity and specificity of 70 percent and, thus, are helpful to identify infants at high risk for severe RSV Infection and need for prophylaxis with palivizumab.

Liu L - One of the best experts on this subject based on the ideXlab platform.

  • Correlative Analysis of Recurrent Respiratory Tract Infection and Immunization in Children
    The Journal of Medical Theory and Practice, 2012
    Co-Authors: Liu L
    Abstract:

    Objective:To study the relation between recurrent Respiratory Tract Infection and immune factors in children so as to better guide treatment.Methods:Children with recurrent Respiratory Tract Infection and normal children were blood test IgG,IgA,IgM,T cell subsets and CD+4/CD+8 ratio were compared.Results:Immune dysfunction is obvious in recurrent Respiratory Tract Infection children.Conclusion:The imbalance of immunity play an important role in recurrent Respiratory Tract Infections.So immune regulation should be the main treatment.

Jaime Fergie - One of the best experts on this subject based on the ideXlab platform.

Marcus Herbert Jones - One of the best experts on this subject based on the ideXlab platform.

Constanze Sommer - One of the best experts on this subject based on the ideXlab platform.

  • risk factors for severe Respiratory syncytial virus lower Respiratory Tract Infection
    The Open Microbiology Journal, 2011
    Co-Authors: Constanze Sommer, Bernhard Resch, Eric A F Simoes
    Abstract:

    RSV Infection is a leading cause of lower Respiratory Tract Infection, especially in High-risk infants with a history of prematurity, bronchopulmonary dysplasia (BPD), congenital heart disease (CHD), neuromusculair impairment, immunodeficiency, and Down syndrome. Host related risk factors that have been identified to be associated with severe RSV related lower Respiratory Tract Infection include young age below 6 months at the beginning of RSV season, multiple birth, male sex, low socioeconomic status and parental education, crowded living conditions, young siblings, maternal smoking and indoor smoke pollution, malnutrition/small for gestational age, family history of atopy or asthma, low cord serum RSV antibody titers, and living at altitude. Risk factors increasing the risk of acquisition of RSV have been identified to be birth before and/or during RSV season, day care attendance, presence of older siblings in school or day-care, and lack of breast feeding. Some of these risk factors are discussed controversially and some of them are found continuously throughout the literature. Given the high cost of RSV prophylaxis, especially for the large population of late preterm infants, algorithms and risk score systems have been published that could identify high-risk infants for treatment with palivizumab out of this gestational age group. Several models reported on an average sensitivity and specificity of 70 percent and, thus, are helpful to identify infants at high risk for severe RSV Infection and need for prophylaxis with palivizumab.